Abeona Therapeutics (ABEO) Misses Q3 EPS by 1c

Abeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($1.48), $0.01 worse than the analyst estimate of ($1.47).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• United Community Banks sells equipment finance unit for $1.9 billion
• Medtronic completes $550 million Scientia Vascular acquisition